CCM
BSX icon

CAAS Capital Management’s Boston Scientific BSX Stock Holding History

CAAS Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$928K Buy
+9,200
New +$926K 0.1% 191
2024
Q4 		– Sell
-100
Closed -$8.38K – 397
2024
Q3 		$8.38K Sell
100
-4,100
-98% -$323K ﹤0.01% 406
2024
Q2 		$323K Buy
+4,200
New +$307K 0.1% 128
2024
Q1 		– Sell
-1,000
Closed -$57.8K – 527
2023
Q4 		$57.8K Buy
+1,000
New +$53.4K 0.01% 428
2023
Q2 		– Sell
-12,700
Closed -$635K – 698
2023
Q1 		$635K Buy
+12,700
New +$599K 0.03% 355
2022
Q2 		– Sell
-205,000
Closed -$9.08M – 900
2022
Q1 		$9.08M Buy
+205,000
New +$8.88M 0.37% 84
2020
Q3 		– Sell
-670,000
Closed -$23.5M – 486
2020
Q2 		$23.5M Buy
+670,000
New +$24.1M 0.77% 34

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CAAS Capital Management's BSX Position: Q1 2025 in Review

CAAS Capital Management opened a new position in Boston Scientific (BSX) in Q1 2025: 370 shares worth $37.3K. The stake represents ﹤0.01% of the portfolio and ranks #433 among its holdings. This is a return to the name: CAAS Capital Management previously reported a position in BSX as recently as Q4 2021.

CAAS Capital Management first reported a position in BSX in Q4 2020 and has held it in 6 quarters since. The position peaked at $1.64M in Q1 2021. 1,642 funds tracked by Wall St. Rank hold BSX as of Q1 2025.

  • CAAS Capital Management held 370 shares of Boston Scientific worth $37.3K as of Q1 2025.
  • Boston Scientific was a new CAAS Capital Management position in Q1 2025.
  • Boston Scientific made up ﹤0.01% of CAAS Capital Management's portfolio in Q1 2025, its #433 holding.
  • CAAS Capital Management first reported a position in Boston Scientific in Q4 2020 and has held it in 6 quarters since.
  • CAAS Capital Management's Boston Scientific position peaked at $1.64M in Q1 2021.
  • 1,642 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2025.

Based on CAAS Capital Management's 13F filing for Q1 2025, filed 1 May 2025.